{
    "nct_id": "NCT05586360",
    "official_title": "T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer",
    "inclusion_criteria": "1. Men with pathologically-confirmed localized prostate cancer determined to be intermediate (stage T2b, or Gleason 7, or PSA 10-20 ng/mL) or high risk (stage T2c, or PSA >/=20 ng/mL, or Gleason >/=8) of biochemical recurrence at the time of biopsy\n2. Electing to undergo prostatectomy;\n3. Ability to provide written informed consent and willing to complete study procedures.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Current statin use or use of non-statin lipid-lowering drug (fibrates, bile acid sequestrants, or niacin);\n2. Current use of medications contraindicated for concomitant use with 40mg simvastatin:\n\n   * Gemfibrozil\n   * Cyclosporine\n   * Danazol\n   * CYP3A4 inhibitors: itraconazole; ketoconazole; posaconazole; erythromycin; clarithromycin; telithromycin; HIV protease inhibitors; boceprevir; telaprevir; nefazodone\n3. Current use of medications requiring lower dose of simvastatin not already listed as exclusions criteria:\n\n   * Verapamil\n   * Diltiazem\n   * Amiodarone\n   * Ranolazine\n   * Calcium channel blockers: verapamil; diltiazem; amlodipine\n4. Men with low-density lipoprotein cholesterol <50mg/dL\n5. Statin use in the previous 12 months;\n6. Discontinued statin use because of statin-related adverse event;\n7. Evidence or suspicion of metastases;\n8. Prior neoadjuvant or adjuvant chemotherapy, hormone therapy, or radiation therapy;\n9. History of non-prostate cancer other than non-melanoma skin cancer in the last 24 months;\n10. Diagnosed diabetes or currently taking diabetes medications\n11. Prior myocardial infarction or stroke\n12. Chronic liver disease (hepatitis or cirrhosis) or abnormal liver function (>1.5x clinical laboratory's upper limit of normal alanine aminotransferase);\n13. Stage 4 or 5 chronic kidney disease (Creatinine clearance / estimated glomerular filtration rate < 30 mL/min calculated by Cockgroft-Gault formula);\n14. History of myopathy or inflammatory muscle disease (>3x clinical laboratory's upper limit of normal creatine kinase).",
    "miscellaneous_criteria": ""
}